International Meeting on Antimicrobial Chemotherapy in Clinical Practice (ACCP) October 16-19, 2003

Similar documents
Mestre-Venice, October 25 th -26 th NH Laguna Palace Hotel Mestre, Venice

2017 Introduction to Infectious Diseases Clinical Seminar Saturday 30th September - Sunday 1st October 2017 Hotel Grand Chancellor Hobart, Tasmania

12 th Biennial STVM Conference 2014

2017 Introduction to Infectious Diseases Clinical Seminar Saturday 30th September - Sunday 1st October 2017 Hotel Grand Chancellor Hobart, Tasmania

Course Coordinators. Course Objectives. Target Audience

LEGAL SEMINAR on Legal Issues in Receivables Finance

LEGAL Training on General Rules of International Factoring

CALL FOR ABSTRACT. Under the Patronage of H. H. Sheikh Nahayan Mabarak Al Nahayan Minister of Education and Chancellor of the UAE University

Marco Tinelli. Giampiero Carosi

LEGAL Seminar on General Rules of International Factoring

What is the problem? Latest data on antibiotic resistance

European Regional Verification Commission for Measles and Rubella Elimination (RVC) TERMS OF REFERENCE. 6 December 2011

TRAINING CLUB LISTED STATUS APPLICATION FORM

Operational Workshop on International Factoring and edifactoring.com

WEBINARS on. FCI Essentials. February 2019

REGIONAL CONFERENCE ON FACTORING IN AFRICA

Marc Decramer 3. Respiratory Division, University Hospitals Leuven, Leuven, Belgium

Report on the APUA Educational Symposium: "Facing the Next Pandemic of Pan-resistant Gram-negative Bacilli"

National Surveillance of Antimicrobial Resistance

CME/CE QUIZ CME/CE QUESTIONS. a) 20% b) 22% c) 34% d) 35% b) Susceptible and resistant strains of typical respiratory

IV Symposium of Tropical Health/COST Action CM 1307 (WG3 and WG4) Joint Meeting Priorities in Tropical Health and parasite borne disease: new drugs

WELCOME International Meeting on Emerging Diseases and Surveillance 2007

JOHN ROGERSON Advanced Dog Behaviour Counselling course

Tackling the need for new antibacterial drugs

OIE Platform on Animal Welfare for Europe

2017 CORPORATE MEMBERSHIP PROGRAM

ANTIMICROBIAL CONGRESS Amelioration in Research to Retried Antibiotics

The UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England

Antimicrobial Stewardship Strategy: Antibiograms

Factoring Training Workshop

ANTIBIOTICS: TECHNOLOGIES AND GLOBAL MARKETS

Meropenem for all? Midge Asogan ICU Fellow (also ID AT)

Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel:

Listed Status Club (Obedience) APPLICATION FORM

GUIDELINES FOR THE PARTICIPANTS

Barriers to Intravenous Penicillin Use for Treatment of Nonmeningitis

National Rabbit Breeds and Rex Rabbit Breeders Club, ÚOK for rabbits breeding and SZCH

SPONSOR CONTRACT WORKINGDOGMAGAZINE.COM JULY 16, 17, HILTON ST. LOUIS AT THE BALLPARK

World Beauceron Special in Stockholm, Sweden, within the World Dog Show 2008 Circuit

OIE Reference Laboratory Reports Activities

Bacterial Resistance of Respiratory Pathogens. John C. Rotschafer, Pharm.D. University of Minnesota

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

AALAS affiliate BETTER EDUCATION FOR BETTER SCIENCE

Antibiotic stewardship Implementing Strategies

Clinical Policy: Clindamycin (Cleocin) Reference Number: CP.HNMC.08 Effective Date: Last Review Date: Line of Business: Medicaid - HNMC

FEDERATION COLOMBOPHILE INTERNATIONALE Founded on 9 January 1948.

Summary of the latest data on antibiotic resistance in the European Union

Global Strategies to Address AMR Carmem Lúcia Pessoa-Silva, MD, PhD Antimicrobial Resistance Secretariat

Annual General Meeting & Conference 2011

Antibiotic resistance in West Africa

7th International Course in PEDIATRIC AIRWAY: LIVE SURGERY, LECTURES, ALBATROSS CASES

OIE Collaborating Centres Reports Activities

Doxycycline for strep pneumonia

Summary of the latest data on antibiotic consumption in the European Union

Healthcare Facilities and Healthcare Professionals. Public

19TH ANNUAL WIGGLE WAGGLE WALK

Combating Antibiotic Resistance: New Drugs 4 Bad Bugs (ND4BB) Subtopic 1C. Seamus O Brien and Hasan Jafri Astra Zeneca and MedImmune

Define evidence based practices for selection and duration of antibiotics to treat suspected or confirmed neonatal sepsis

Non-Clinical Benefits of Evidence-Based Veterinary Medicine

7th International Course in PEDIATRIC AIRWAY: LIVE SURGERY, LECTURES, ALBATROSS CASES

Antimicrobial Resistance Initiative

Looking forward to seeing you in Vechta.

Rational management of community acquired infections

Clinical Guideline. District Infectious Diseases Management. Go to Guideline. District Infectious Diseases Management CG 18_24

ASSEMBLY HALL/FESTIVAL HALL, UNIVERSITY OF BONN, GERMANY

Resolution adopted by the General Assembly on 5 October [without reference to a Main Committee (A/71/L.2)]

EFSA s activities on Antimicrobial Resistance

World Health Organization Emerging and other Communicable Diseases, Surveillance and Control

Clinical Policy: Linezolid (Zyvox) Reference Number: CP.PMN.27 Effective Date: Last Review Date: Line of Business: HIM*, Medicaid

OIE strategy on AMR and the Prudent Use of Antimicrobials

Tel: Fax:

Antimicrobial Stewardship in the Hospital Setting

Rights and responsibilities of Permanent Delegates and role of National Focal Points

COMMISSION OF THE EUROPEAN COMMUNITIES

NOVEMBER 9 10 INFORMATIONSHEET EXHIBITORS

CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

RESISTANCE, USE, INTERVENTIONS. Hugh Webb

Assembly Hall/Festival Hall, University of Bonn, Germany

MANAGEMENT STRATEGIES FOR ORTHOPEDIC IMPLANT-ASSOCIATED INFECTIONS. 5-6 March 2018 Berlin Germany. Endorsed by:

Terms and Conditions

Global Conference on Rabies Control: Towards Sustainable Prevention at the Source

The FCI Initiative for Young Dog Lovers Worldwide. Basic recomendations ORGANIZING YOUTH ACTIVITIES FOR CYNOLOGICAL VENUES.

Table Of Content. D Final Report 'Primary Care Anti-infective agent prescribing for Common

General Approach to Infectious Diseases

against Clinical Isolates of Gram-Positive Bacteria

Ottawa Valley Golden Retriever Club

3 rd International Conference on Veterinary and Animal Science

ECDC activities on antimicrobial resistance & healthcare-associated infections (ARHAI Programme) Ülla-Karin Nurm, ECDC Tallinn, 13 May 2013

moxifloxacin intravenous, 400mg/250mL, solution for infusion (Avelox ) SMC No. (650/10) Bayer Schering

Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals

Assembly Hall/Festival Hall, University of Bonn, Germany

Section BIRDS. Delivery date: Tuesday, 06. November am 08 pm Judging: Wednesday, 07. November 2018 Thursday, 08.

from Endell Veterinary Group LLP Save money and pay monthly for your pet s essential preventive care with our Pet Health Plans

Contents & results of 3 years of VMP FP training Susanne Münstermann OIE Scientific and Technical Department

The OIE Manual of Diagnostic Tests and Vaccines for Terrestrial & Aquatic Animals

Antimicrobial Cycling. Donald E Low University of Toronto

Clinical Policy: Linezolid (Zyvox) Reference Number: CP.PMN.27 Effective Date: Last Review Date: Line of Business: Oregon Health Plan

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases

OIE Collaborating Centres Reports Activities

Office International des Épizooties World Organisation for Animal Health created in 1924 in Paris

Transcription:

International Meeting on Antimicrobial Chemotherapy in Clinical Practice (ACCP) rd October 16-19, 2003 Centro Congressi - Grand Hotel Miramare Santa Margherita - Portofino (Genova) - Italy Advanced Program and Call for Abstracts Organized in collaboration with Italian Credits (ECM) registred

Congress Web Site www.accp.it 2 President of the Congress D. Bassetti (Genova, Italy) Scientific Secretariat M. Bassetti M. Cruciani A. Di Biagio Infectious Diseases Department University of Genova - S. Martino Hospital Largo R. Benzi, 10-16132 Genova, Italy Phone: +39 010 5552668 Fax : +39 010 3537680 e-mail: mattba@tin.it bassetti@unige.it Scientific Committee J. Acar (Paris, France) D. Adam (Munich, Germany) L. Allegra (Milan, Italy) V. T. Andriole (New Haven, USA) P. Ball (Fife, Scotland) N. Clumeck (Brussels, Belgium) W. Craig (Madison, USA) P. Dellamonica (Nice, France) R. G. Finch (Nottingham, UK) J. Garau (Barcelona, Spain) J. A. Garcìa Rodrìguez (Salamanca, Spain) G. Gialdroni (Pavia, Italy) H. Giamarellou (Athens, Greece) R. Gòmez-Lus (Saragozza, Spain) E. Gotuzzo (Lima, Peru) C. Grassi (Pavia, Italy) J. Klastersky (Brussels, Belgium) L. Mandell (Hamilton, Canada) T. Mazzei (Florence, Italy) R. C. Moellering (Boston, USA) M. Moroni (Milan, Italy) J. C. Pechère (Geneva, Switzerland) E. Rubinstein (Tel Aviv, Israel) U. B. Schaad (Geneva, Switzerland) J. J. Schentag (Buffalo, USA) P. Shah (Frankfurt, Germany) S. Vella (Rome, Italy) F. Waldvogel (Geneva, Switzerland) J. D. Williams (London, UK) L. S. Young (San Francisco, USA) Organizing Secretariat Progetti di Congress Studio srl Piazzale S. Turr, 5 20149 Milano, Italy Phone: +39 02 3196951 Fax: +39 02 33604939 e-mail: info@congress-studio.it

Welcome Address Dear Colleagues and Friends, On behalf of the Organizing and Scientific Committee we invite you with great pleasure to the 3rd International Meeting on Antimicrobial Chemotherapy in Clinical Practice (ACCP), to take place 16-19 October 2003 in Santa Margherita, Italy. The field of infectious disease is in constant flux. While some diseases are close to eradication, new disease entities continue to appear and others reemerge owing to changing public health circumstances or the development of drug resistance. It is difficult for even the most conscientious practitioner to be well versed in the literature, interact with colleagues in teaching and learning settings, and fulfill daily professional obligations. It is essential for practicing physicians to keep abreast of the continuous advances in diagnostic techniques and therapeutics to provide optimal patient care. The International Meeting on Antimicrobial Chemotherapy in Clinical Practice is designed to provide such an update in these important areas, utilizing a faculty of internationally recognized experts who can communicate practical advice to clinicians. The 3rd ACCP program provides a forum for the presentation of posters and oral communications. We welcome and encourage you to share the results of your investigations and new clinical or laboratory data with all attendees by submitting one or more abstracts to the Scientific Committee for consideration. The meeting will be held in one of the most beautiful settings in the world, the Ligurian coast, when both the climate and scenery will be at their best. The organizers of the 3rd ACCP believe that the scientific program as well as the beauty and culture of Liguria and Italy will make this meeting an exciting, stimulating and memorable event for all participants. We invite you to the 3rd and look forward to seeing you in Liguria. Dante Bassetti President 3rd ACCP 3

Advanced Program 16-19 October 2003 Thursday, October 16 2003 17.30 Opening lectures Chairs: P. Crovari (Italy), G. Gialdroni (Italy) The non anti-hiv effects of the protease inhibitors B. Ensoli (Italy) Clinical and epidemiological aspects of SARS L. Allegra (Italy) 19.00 Welcome reception Friday, October 17 2003 8.30-10.00 Symposium: Proper use of antibiotics in hospital Chairs: T. Mazzei (Italy), P. Shah (Germany) Introduction T. Mazzei (Italy) Use of antibiotics and resistance in hospital G. Tillotson (USA) Mutant prevention concentration J. Blondeau (USA) PK/PD in the selection of antibiotics A. Novelli (Italy) Conclusions and discussion P. Shah (Germany) 10.00-11.00 Concise Symposium: Long term successful in the management of HIV infection Chairs: D. Bassetti (Italy), G. Carosi (Italy) The evolving epidemic of HIV/AIDS in the world S. Vella (Italy) When to start which to start G. Carosi (Italy) 4 The role of once-daily for protease inhibitors D. Back (UK)

11.30-13.15 Symposium: Extending the spectrum of antifungal therapy Chairs: V.T. Andriole (USA), P. Martino (Italy) Introduction P. Martino (Italy) The growing problem of serious fungal infections T.F. Patterson (USA) New treatment strategies for invasive Candida infections F. Menichetti (Italy) Changing the course of aspergillosis therapy T. Walsh (USA) Empirical management of fungal infections in neutropenic patients J. Klastersky (Belgium) Conclusions and discussion V.T. Andriole (USA) 13.15-14.30 Poster discussion and lunch 14.30-16.00 Symposium: Appropriate use of antibiotics in ICU infections Chairs: E. Rubinstein (Israel), T. Mazzei (Italy) Introduction E. Rubinstein (Israel) Pharmacological properties of anti Grampositive weapons T. Mazzei (Italy) New options for serious Gram-positive infections J. Garau (Spain) Optimising Empiric Therapy in the ICU- A clinical and cost-effective approach D. Nathwani (UK) Conclusions and discussion T. Mazzei (Italy) 5

Advanced Program 16-19 October 2003 16.15-18.15 Symposium: Update on Gram-positive infections Chairs: F. de Lalla (Italy), P. Serra (Italy) Resistance to Staphylococcus aureus: should global epidemiology patterns influence the choice of therapy? R.C. Moellering (USA) Interchange of resistance genes among enterococci, staphylococci and streptococci R. Gomez Lus (Spain) Macrolide resistance in streptococci other than pneumococci and Streptococcus pyogenes J. Garau (Spain) Enterococci: a road map on how to prevent the emergence and transmission of antimicrobial resistance E. Rubinstein (Israel) S. pneumoniae in Europe: why does resistance matter? P. Dellamonica (France) 6

Saturday, October 18 2003 8.30-10.00 Symposium: Emerging pathogens in the hospital setting and strategies to help control them Chairs: E. Bouza (Spain), J.C. Pechère (Switzerland) Introduction J.C. Pechere (Switzerland) Overview on resistance trend in cephalosporins, fluoroquinolones and carbapenems M. Venditti (Italy) Current options in the management of serious infections in ICU E. Bouza (Spain) Current options in the management of sepsis LS. Young (USA) Discussion and conclusions E. Bouza (Spain) 10.15-10.45 Lecture Chair: R. Cauda (Italy) Bacterial Endocarditis: The Continued Power of Detailed Observation for 100 Years V. Quagliarello (USA) 11.15-13.00 The approach to the community-acquired respiratory infections: an evolving scenario Chairs: L. Allegra (Italy), C. Grassi (Italy) Introduction C. Grassi (Italy) Epidemiological features of bacterial resistance in respiratory tract infections J.A. Garcia Rodriguez (Spain) PK/PD of new quinolones J.J. Schentag (USA) Monotherapy versus combination therapy in the treatment of CAP P. Ball (UK) 7

Advanced Program 16-19 October 2003 Rational approach to patients with AECB S. Esposito (Italy) Conclusions and discussion L. Allegra (Italy) 13.00-14.30 Poster discussion and lunch 14.30-16.00 Symposium: Advantages of combination therapy in the treatment of infections Chair: J. Garau (Spain) Introduction on HIV therapy TBD Sequencing HAART in clinical practice A. D Arminio Morforte (Italy) PK/PD properties of fluoroquinolones plus betalactams in ICU infections W. Craig (USA) Current options in serious bacterial infections H. Lode (Germany) Conclusions and discussion J. Garau (Spain) 16.15-16.45 Lecture Chair: A. Aceti (Italy) Echinocandins in clinical practice R. Martino (Spain) 16.45-18.00 Symposium: Overview on pediatric infectious diseases Chairs: F. Fraschini (Italy), G. Serra (Italy) The role of fluoroquinolones in pediatrics US. Schaad (Switzerland) Otitis media and vaccines A. Boccazzi (Italy) 8 Short course versus long term antibiotic therapy in upper and lower respiratory tract infections D. Adam (Germany)

Sunday, October 19 2003 8.30-9.00 Lecture Chair: L. Minoli (Italy) CMV infections and solid organ transplantation G.P. Basadonna (USA) 9.00-10.00 Concise Symposium: CAP and atypical pathogens Chairs: L. Mandell (Canada), G. Rossi (Italy) Atypical pathogens in lower respiratory tract infections F. Blasi (Italy) Current role of macrolides in the treatment of CAP L. Mandell (Canada) 10.30-11.00 Lecture Chair: US. Schaad (Switzerland) Update on travelers diarrhea E. Gotuzzo (Peru) 11.00-12.00 Concise Symposium: The last enemies Chairs: P. Crovari (Italy), G.Palù (Italy) Anthrax MR. Gismondo (Italy) Coronavirus TBD 9

Scientific Informations All participants are invited to submit abstracts on one of the topics listed below for presentation at the 3rd ACCP. Deadline for abstract submission: July 31, 2003 Abstracts may only be submitted via internet on the homepage www.accp.it. Avoid submission within 48 hours of the deadline for best system performance! In order to standardise the abstract layout we ask you to read the preparation guidelines below CAREFULLY! Guidelines for submission of abstracts: 1. Abstracts may only be submitted via Internet. Abstracts submitted via Fax or E-mail will not be accepted. 2. All abstracts must be submitted and presented in English. 3. Abstracts must contain original material neither published nor presented elsewhere prior to October 16, 2003. 4. Please structure your abstract using the following headings: Objectives Results Methods Conclusions Abstracts should be informative and not just promise further investigation. 5. Abstracts may not be longer than 2500 characters including spaces. 6. Avoid complex mathematical formulae, Greek letters and symbols. Instead of IFN- use for example IFN-γ or IFN-γ, etc. 7. Authors should indicate their presentation preference: Poster presentation Oral or Poster presentation 8. After having submitted your abstract, you will receive a confirmation by e-mail 9. Abstracts will be subject to a blind peer view by the members of the Programme Committee and external experts. 10. Authors will be notified of the acceptance in September 2003 by e-mail. 11. The presenting authors must register for the conference by September 30, 2003. If by this date the registration fee has not been received, the abstract will not be published. Authors with accepted abstracts are entitled to the lower registration fee if registered before September 30, 2003. 12. If an abstract is accepted, authors must attend the congress and present it in person. If a presenting author withdraws an abstract after, September 30, 2003, or does not attend the session for which he or she has been scheduled, a penalty will incur prohibiting the author from presenting papers at the ACCP meetings for a period of 3 years. Those subject to this penalty will be informed in writing. If you have difficulties in submitting your abstracts or if you need any further information, please contact the Abstract hotline: 10 Phone: +39 010 555 51 32 (Monday - Friday during CET business hours)

Topics New antibiotics for adults and children New antiviral agents: Pharmacokinetics, mechanisms of action, clinical trials HIV therapy Progresses in antifungal therapy Pediatric Infections (including vaccines) All about streptococci Staphylococcus aureus: bench to bedside and beyond Sexually transmitted diseases Appropriate use of antibiotics in hospital and in community Transplant infections Hepatitis B and C: new frontiers Antimicrobial resistance: epidemiological features and clinical relevance Antivirals resistance: what s new? Publication All accepted abstracts will be published as a supplement to a journal. The Abstract book will be handed out to all participants upon registration at the congress and is included in the registration fee. Nosocomial infections and Infection control Bioterrorism Health care associated infections CNS infections Bugs and bones: osteomyelitis and prosthetic joint infections Emerging and reemerging pathogens Treatment of endocarditis Pharmacokinetics and pharmacodynamics of antibiotics Travel medicine Antifungal susceptibility: role of testing and clinical relevance Pneumonia: emerging plagues and evolving management Poster/Oral Presentations Accepted abstracts are to be presented either as poster or oral presentation. The final decision of the presentation format will be made by the Programme Committee. Full instructions concerning the preparation and presentation of both forms of presentation will be given in the acceptance e-mail. 11

General Informations (in alphabetic order) 12 Abstract Book Abstracts accepted for oral or poster presentation during the congress will be published in the official book of the meeting, which is included in the congress fee and distributed, along with other congress documentation, upon registration at the congress. Banking and Exchange Facilities The Italian monetary system is EURO. Foreign currency may be changed at banks during normal opening hours as well as at hotels, at the airport and in exchange offices. All major credit cards are accepted in most hotels, restaurants and shops. Climate October is the early days of the autumn with mild weather of approximately 20-24 degrees Celsius at daytime and about 15-18 degrees Celsius in the evenings. It is recommended to bring along raincoat and umbrella for possible rainshowers. CME/ECM Formal request for credits will be submitted to the Italian Ministry of Health in due time. Credits obtained will be displayed on program and on web site as they will be notified. Crediti will be only for Italian physicians Congress Venue: Conference Center Grand Hotel Miramare Lungomare Milite Ignoto, 30 16038 S. Margherita Ligure (Genova) Phone: +39 0185 287013 Fax: +39 0185 284651 Correspondence All correspondence before and after the meeting: 3rd Progetti di Congress Studio Piazzale S. Turr,5 20149 Milano - Italy Phone: +39 02 3196951 Fax: +39 02 33604939 email: accp@congress-studio.it Currency The official meeting currency is EURO. 1 EURO= 1,16 USD Electricity The electricity current in Italy is 220 volts. Exhibition During the meeting a commercial exhibition will be arranged. Companies from all over the world will be given the opportunity to display products, services and technical innovations. The exhibition will be situated in a hall close to the lecture halls in order to offer maximum visibility and availability to the participants.

Final program The final program will be distributed to all participants upon registration along with all other congress documentation. Please visit the 3rd ACCP meeting homepage offering continuously updated information:http://www.accp.it Hotel Accommodation Hotel accommodation has been reserved in Santa Margherita Ligure. Request will be satisfied on a first-come first served basis. If single rooms are not available, double room for single occupancy will be reserved. To reserve, please fill the Hotel reservation form. For room rates please see the Hotel reservation form. Insurance The meeting organizers cannot accept liability for personal injuries sustained, or for loss or damage of property belonging to congress participants, either during or as result of the meeting. Language The meeting language is English. Simultaneous translation could be provided. Letter of invitation The meeting will be pleased to send a letter of invitation to any individual requesting one. It is to be understood that such an invitation is intended to help potential participants raise travel funds or obtain a visa. It is not a committment on the pat of the meeting to provide any financial support. You may request such a letter from the organizing secretariat. Method of Payment Payment may be made by the following methods: Cheque will be accepted only Italian Cheque made payable to Progetti di Congress Studio srl Bank to Bank transfer Bank San Paolo IMI- Via Imbonati 64/A Milan For foreigner delegates: IBAN IT95 E010 2501 6051 0000 0014 242 BIC IBSPITTM For Italian delegates: CAB 01605, ABI 01025, C/C 10/14242 Credit cards Payment is accepted by Visa, Mastercard, CartaSI. If you are paying by credit card please complete the enclosed form. Poster exhibition The poster area will be situated right next the registration area in order to attract maximum attention. Information regarding poster format, set-up and dismantling will be sent to authors along with their notification of acceptance. Press Accredited journalists are welcome to cover the 3rd. Please use the enclosed registration form for your participation, on which you are required to clearly mark "Press" at the title line, followed by a copy of your press identification. 13

General Informations (in alphabetic order) Registration Registration can be made in advance of the Congress or on site. Registration fee (inclusive of VAT) Standard Up Late August to July 31 st 1 st onwards Active participant 400 500 Accompanying person 250 320 Physicians under 30, Residents and Fellows (with ID) 150 200 Students (with University ID) Free Free Registration fee for active participant includes: Admittance to the scientific sessions Congress Kit Welcome reception Working lunches Registration fee for accompanying person includes: Accompanying program Welcome reception Telephones Pay phones and credit card phones are available at congress center as well as in the city. Please be aware that mobile telephones must be switched off during all sessions. Registration cancellation Provided that written notice is received by September 15th, the registration fee will be refunded less a 50 administration charge. No refunds will be made for any cancellation made after this date. Time Italy is 1 hour ahead of Greenwich Mean Time (GMT). 14

Acknowledgements The Organising Committee expresses its thanks and appreciation to those who are generously contributing to the success of the 3 rd International Meeting on Antimicrobial Chemotherapy in Clinical Practice Abbott Bayer Grünenthal-Formenti GSK Merck Sharp & Dohme Pfizer Pharmacia & Upjohn Wyeth 15

Arrivederci to... 4International Meeting on Antimicrobial Chemotherapy in Clinical Practice (ACCP) th October, 2005 ACCP 2005